Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
ESMO Open|June 20, 2020
New emerging targets in cancer immunotherapy: the role of VISTAMarco Tagliamento, Paolo Bironzo, Silvia NovelloAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 24, 2024
Tackling Non-Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and OutcomesJuan Carlos Laguna, Marco Tagliamento, Matteo Lambertini, et al.Current Opinion in Supportive and Palliative Care|August 5, 2022
The evolving scenario of cancer care provision across the COVID-19 pandemic in EuropeMarco Tagliamento, Francesca Poggio, Marta Perachino, et al.Immunotargets and Therapy|June 30, 2021
VISTA: A Promising Target for Cancer Immunotherapy?Marco Tagliamento, Elisa Agostinetto, Roberto Borea, et al.Expert Opinion on Biological Therapy|June 26, 2018
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccineMarco Tagliamento, Erika Rijavec, Giulia Barletta, et al.Cancer Treatment Reviews|April 26, 2022
The use of immunotherapy in older patients with advanced non-small cell lung cancerMarco Tagliamento, Maxime Frelaut, Capucine Baldini, et al.Expert Opinion on Drug Safety|March 30, 2017
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancerCarlo Genova, Giovanni Rossi, Erika Rijavec, et al.Expert Review of Respiratory Medicine|January 10, 2020
Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectivesCarlo Genova, Giovanni Rossi, Marco Tagliamento, et al.Immunotherapy|June 4, 2019
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosusMarco Tagliamento, Francesco Grossi, Sabrina Paolino, et al.Endocrine|March 7, 2019
RETRACTED ARTICLE: Can baseline endocrinological examination and thyroid ultrasound predict the development of thyroid disease in immunotherapy-treated patients? Results from a prospective, single-center, open-label studyStefano Gay, Giovanni Rossi, Giuliana Corica, et al.Pageof 9